Company / Income Tax per Share
Fulgent Genetics, Inc. Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$0.27
FY2025
5-year range
-$0.27 / $5.94
FY2021-FY2025
Trend
+0.8%
vs FY2024
Sector context
#155 of 160
Health Care
What the data says
Among 160 Health Care companies, Fulgent Genetics, Inc. is in the top 3% for income tax per share. Income Tax per Share has fluctuated over the past 10 years, ranging from $-0.27 in FY2024 to $5.94 in FY2023.
Based on SEC 10-K filings.
-0.27 in FY2025.
Improved from $5.94 to $-0.27 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 160This company -$0.27 Sector average $1.04
▼
-126.2% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 0.8% year-over-year.
- Ranks #155 out of 160 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2023.
- Lowest income tax per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.27 | +0.8% |
| FY2024 | -$0.27 | -104.6% |
| FY2023 | $5.94 | +146.9% |
| FY2022 | $2.40 | +157494.1% |
| FY2021 | $0.00 | -100.0% |
| FY2020 | $3.38 | +170325.6% |
| FY2019 | $0.00 | +103.5% |
| FY2018 | -$0.06 | +1.0% |
| FY2017 | -$0.06 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026